HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality of Life

Listen Now

Topics Covered

• HER2-Positive Metastatic Breast Cancer
• Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
• Standard Treatment Options, Including Targeted Therapy
• How Biomarker Testing Informs Treatment Decisions
• New & Emerging Targeted Treatments
• Updates on Investigational New Drugs in Clinical Trials
• How Research Contributes to Your Treatment Options
• What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
• Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
• Questions for Our Panel of Experts

Our Panel of Experts

Julie G. Fisher, MD

Medical Director, Levine Cancer Institute, Co-Director, Sandra Levine Young Women’s Breast Cancer Program, Associate Hematology/Oncology Fellowship Director, Levine Cancer Institute

Dame Idossa, MD

Assistant Professor of Medicine, Breast Oncologist, Division of Hematology and Oncology, University of Minnesota

Shimoli V. Barot, MD

Associate Staff, Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Center

Saba Shaikh, MD

Assistant Professor, Division of Hematology/Oncology, Mays Cancer Center at UT Health San Antonio, MD Anderson Cancer Center

Cassie Spector, MSW

Breast and Gynecological Cancers Program Coordinator, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on April 24, 2024.